Related Experiment Video
Updated: Feb 12, 2026

A Protocol for the Production of Gliadin-cyanoacrylate Nanoparticles for Hydrophilic Coating
Published on: July 8, 2016
The Validation of the RIDA®QUICK Gliadin for AOAC Research Institute
Markus Lacorn1, Thomas Weiss1, Nicole Klass2
1R-Biopharm AG, An der neuen Bergstrasse 17, D-64297 Darmstadt, Germany.
Abstract:
RIDA®QUICK Gliadin is an immuno-chromatographic test for the detection of gluten in foods, on surfaces, and in Cleaning-in-Place (CIP) waters. This test kit has been adopted as Final Action AOAC INTERNATIONAL Official Methods of AnalysisSM 2015.16 for gluten in corn products. The assay is based on the monoclonal antibody R5, which recognizes gluten in wheat, barley, and rye. Four different surfaces were contaminated with a gliadin material and analyzed by a direct swabbing of the surface with the dip-stick. The outcome was an LOD95% concentration of the assay between 1.6 and 3.0 μg/100 cm2 gluten. For CIP waters that contain cleansing reagents, 100% positive results were obtained for minimum gluten concentration between 50 and 100 ng/mL. If the CIP water does not contain these reagents, the minimum detectable gluten level is 10 ng/mL. The independent validation study consisted of a method comparison study of recovery from a CIP solution and from a stainless-steel surface. The test kit was evaluated at six different concentration levels for both matrices, with 20 or 30 replicates per concentration level. The probability of detection was calculated for each contamination level. Additionally, the LOD95% concentration was estimated for each matrix analyzed.
Related Concept Videos
Reliability and Validity
Data Validation
Key parameters for method validation include:
Data Validation
Nursing assessment guides are generally based on holistic models rather than medical...
Formulating and Validating Nursing Diagnosis I
There are thirteen domains...
Formulating and Validating Nursing Diagnosis II
Risk nursing diagnoses represent clinical judgments of an individual, family, or community more vulnerable to developing the health problem than others...
In Vitro Drug Release Testing: Overview, Development and Validation

